Translating Research into Highest Quality Patient Care

DSRB - Introduction


The Domain Specific Review Board (DSRB)


The NHG Domain Specific Review Board (DSRB) is an independent committee constituted of medical, scientific and nonscientific members, whose responsibility is to ensure the protection of the rights, safety, and well-being of human subjects involved in a research study by, among other things, reviewing, approving, and providing continuing review of research studies, of protocols and amendments, and of the methods and materials to be used in obtaining and documenting informed consent of the research subjects.

The DSRB is empowered under the auspices of the NHG Chairmen Medical Boards Committee, whose authority applies to all research involving patients, staff, premises, or facilities of NHG institutions and all other institutions under its oversight. Other officials of institutions which conduct research under the oversight of NHG DSRB, may not override the decision of DSRB (or REC, where applicable).


The Six Domains
There are currently five Biomedical Domains (A-E) that are based on broad but related disease groupings and a Population Health Domain (F). Each Board is made up of 11-15 members and constituted in compliance with the Singapore Guideline for Good Clinical Practice.

The characteristic of such an arrangement is to ensure that more appropriate expertise can be concentrated within each Domain to assess the scientific and ethical merits of the protocols submitted for ethics review.

The specialties under DSRB are as follows (as of 02 November 2012):


NOTE: For Allied Health, Nursing & Para-clinical research protocols, please select the most appropriate Domain according to the main disease type/condition being studied. Do note that the DSRB may re-assign your application to another Domain upon preliminary review of your application.


 

Domain B – Two Independent Boards (as of 01 February 2011)

Over the years, the volume of research studies submitted to the DSRB has increased significantly. This trend is especially evident for oncology-related clinical research and clinical trials submitted to Domain B.


In order to maintain the high quality of review and ethics oversight, as well as to expand the capabilities of the DSRB to manage the increase effectively, it is necessary for the formation of two independent Boards to oversee the research studies submitted to Domain B. Each Board comprises its own Chairperson and Committee Members and will hold separate meetings every month. The decisions made by each Board will be recognized by the other DSRBs, therefore Investigators will not be allowed to submit the same ethics application more than once.


With effect from 01 February 2011, all new and existing studies under the oversight of Domain B will be triaged to either Domain B Board 1 or Board 2. This will be done by the Domain B Secretariat and Investigators will be notified accordingly. There will be no change to the submission process as Investigators need only indicate that his/her ethics application is submitted to Domain B.

Please contact the Domain B Secretariat if you have further queries.



DSRB Meeting Dates for 2015


Domains

A

B1

B2

C

D

E

F1

F2

Jan

19 Jan 15

20 Jan 15

13 Jan 15

20 Jan 15

22 Jan 15

21 Jan 15

20 Jan 15

21 Jan 15

Feb

16 Feb 15

10 Feb 15

10 Feb 15

17 Feb 15

26 Feb 15

18 Feb 15

17 Feb 15

18 Feb 15

Mar

16 Mar 15

17 Mar 15

10 Mar 15

24 Mar 15

19 Mar 15

18 Mar 15

17 Mar 15

18 Mar 15

Apr

20 Apr 15

21 Apr 15

14 Apr 15

21 Apr 15

23 Apr 15

22 Apr 15

14 Apr 15

15 Apr 15

May

18 May 15

19 May 15

12 May 15

19 May 15

21 May 15

20 May 15

19 May 15

20 May 15

Jun

15 Jun 15

16 Jun 15

09 Jun 15

23 Jun 15

18 Jun 15

17 Jun 15

23 Jun 15

17 Jun 15

Jul

13 Jul 15

21 Jul 15

14 Jul 15

21 Jul 15

23 Jul 15

22 Jul 15

21 Jul 15

22 Jul 15

Aug

17 Aug 15

18 Aug 15

11 Aug 15

18 Aug 15

20 Aug 15

19 Aug 15

18 Aug 15

19 Aug 15

Sep

14 Sep 15

15 Sep 15

08 Sep 15

22 Sep 15

17 Sep 15

16 Sep 15

22 Sep 15

23 Sep 15

Oct

19 Oct 15

20 Oct 15

13 Oct 15

20 Oct 15

22 Oct 15

21 Oct 15

20 Oct 15

21 Oct 15

Nov

16 Nov 15

17 Nov 15

17 Nov 15

17 Nov 15

19 Nov 15

18 Nov 15

17 Nov 15

18 Nov 15

Dec

-

-

-

-

-

-

-

-














Please note that the above timetable is correct as of 30 Dec 2014 and may be subject to change without prior notice.

The above timetable is only for information. Investigators must follow the following deadlines for the submissions to be reviewed accordingly.


Full Board Study Application

  • The submission deadline for new studies requiring full board review is the 1st working day of each calendar month.

  • Studies received by this deadline will be reviewed within the same calendar month*. For example, applications to be reviewed at the meeting in July 2013 must reach DSRB by 1 July 2013.

  • The PI should submit with sufficient lead time for the Department Representative and Institutional Representative to endorse prior to the 1st working day of the month.
  • Submissions received after the 1st working day would be tabled for the subsequent full board meeting.

Full Board Study Amendments

  • Similarly, the deadline for any study amendments (page 44) that require full board review by the DSRB is the 1st working day of each calendar month.*

Exempt and Expedited studies

  • There is no specific deadline for new studies that qualify for exempt (page 63) or expedited (page 66) review. Studies that do not qualify for exempt or expedited review will require full board review by the DSRB.

All new completed applications accepted by the DSRB will be reviewed within thirty calendar days**. However, the time frame from submission to approval will vary depending on factors such as the completeness of the application, complexity of the study, and the response of the Investigator to DSRB's queries.

The DSRB Full Board meeting dates can be downloaded here.

For any further queries, please feel free to contact the DSRB listed below.


* Except in December

** Subject to availability of a meeting quorum




NHG Domain Specific Review Board (DSRB) Contact List

 

 

 

 

Asst Director of OHRPP

Ms NG HWEE HIAN

6496 6017

hwee_hian_ng@nhg.com.sg

Asst Manager of DSRB

Ms FELICIA WONG

6496 6983

felicia_yx_wong@nhg.com.sg

Lead IRB Analyst

Ms LEONG YUAN TING

6496 6955

yuan_ting_leong@nhg.com.sg

Lead IRB Analyst

Ms QIU SHIJIA 

6496 6954

shijia_qiu@nhg.com.sg

 

Domain A

IRB Analyst

Ms TEO YI LING

6340 2410

yi_ling_teo@nhg.com.sg

Asst IRB Analyst

Ms GUO QIANPING

6496 6956

qianping_guo@nhg.com.sg

Asst IRB Analyst

Ms NURLATIFAH BINTE RAZALI

6340 2408

nurlatifah_razali@nhg.com.sg

 

Domain B1

IRB Analyst

Ms JESSICA TEO

6340 2481

jessica_lq_teo@nhg.com.sg

IRB Analyst

Ms JEAN FOO

6496 6958

jean_cy_foo@nhg.com.sg

Asst IRB Analyst

Ms JAYLYNN CHONG

6496 6957

jaylynn_xj_chong@nhg.com.sg

 

 

 

 

Domain B2

IRB Analyst

Ms JEAN FOO

6496 6958

jean_cy_foo@nhg.com.sg

Snr Asst IRB Analyst

Mr EDWIN HONG

6496 6978

edwin_jq_hong@nhg.com.sg

 

 

 

 

Domain C

IRB Analyst

Ms AMBER LIM

6496 6910

amber_sq_lim@nhg.com.sg

Asst IRB Analyst

Ms NURUL HUDA BINTE RAHMAT

6496 6906

huda_rahmat@nhg.com.sg

 

Domain D

Lead IRB Analyst

Ms QIU SHIJIA

6496 6954

shijia_qiu@nhg.com.sg

IRB Analyst (Only for Full Board studies)

Ms AMBER LIM

6496 6910

amber_sq_lim@nhg.com.sg

Asst IRB Analyst

Ms NUR FARZIRA HAIRUDIN         

6496 6959

nur_farzira_hairudin@nhg.com.sg

 

Domain E

IRB Analyst

Ms JULIA NG

6496 6258

julia_sy_ng@nhg.com.sg

IRB Analyst

Ms JASLIN TAN

6496 6016

jaslin_sf_tan@nhg.com.sg

Snr Asst IRB Analyst

Mr EDWIN HONG

6496 6978

edwin_jq_hong@nhg.com.sg

 

Domain F

IRB Analyst

Ms ELING HO

6496 6912

eling_ll_ho@nhg.com.sg

Asst IRB Analyst

Ms GAIYATHRI D/O ELANKOVAN

6496 6964

gaiyathri_elankovan@nhg.com.sg




Download DSRB Contact List
 

Domain Specific Review Board (DSRB)

c/o National Healthcare Group, Research & Development Office (RDO)
Nexus @One-North (South Tower), No. 3 Fusionopolis Link, #03-08, Singapore 138543

T : (65) 6471 3266; F : (65) 6496 6257

E: OHRPP@nhg.com.sg





For ROAM technical support:


For all NHG ROAM Login/Account technical issues, please click here for more information.


For all other ROAM related issues, please send an email containing your Full Name, NRIC/FIN, ROAM User ID / NHG ADID, current Company & Department ,  contact number and the problem in detail to researchonline@nhg.com.sg. We will respond to you within 2 working days.


You may also contact the ITD Helpdesk at 1800 483 4357 and provide the above information to be emailed to us.

 


Last Update  16 March 2015